Biomarker analysis for nanotoxicology

Biomarkers in Toxicology

Volumn , Issue , 2014, Pages 689-695

  Hondroulis, Evangelia ^a   Nelson, Jairo ^a   Li, Chen zhong ^a  

^a Florida International University   (United States)

Author keywords

Biomarkers; Nanomaterial; Nanoparticle; Nanotoxicity; Nanotoxicity biomarker

Indexed keywords

EID: 84902224418     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-404630-6.00040-3     Document Type: Chapter

References (70)

1. Ajayan P.M. Nanotubes from carbon. Chem Rev 1999, 99:1787-1800.
2. Amino N., Hidaka Y. Various types of immunoassay. Nihon Rinsho 1995, 53:2107-2111.
3. Arora S., Rajwade J.M., Paknikar K.M. Nanotoxicology and in vitro studies: The need of the hour. Toxicol Appl Pharmacol 2012, 258:151-165.
4. Atkinson A.J., Colburn W.A., DeGruttola V.G., et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95.
5. Bell A.T. The impact of nanoscience on heterogeneous catalysis. Science 2003, 299:1688-1691.
6. Brunner T.J., Wick P., Manser P., et al. In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 2006, 40:4374-4381.
7. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 1978, 52:302-310.
8. Chang J.S., Chang K.L.B., Hwang D.F., Kong Z.L. In vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ Sci Technol 2007, 41:2064.
9. Chang Y., Yang S.T., Liu J.H., et al. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett 2010, 200:201-210.
10. Chen G., Ke Z., Xu M., et al. Autophagy is a protective response to ethanol neurotoxicity. Autophagy 2012, 8:1577-1589.
11. Choi S.J., Oh J.M., Choy J.H. Human-related application and nanotoxicology of inorganic particles: complementary aspects. J Mater Chem 2008, 18:615-620.
12. Cormode D.P., Jarzyna P.A., Mulder W.J.M., Fayad Z.A. Modified natural nanoparticles as contrast agents for medical imaging. Adv Drug Deliv Rev 2010, 62:329-338.
13. Delfino R.J., Staimer N., Tjoa T., et al. Associations of primary and secondary organic aerosols with airway and systemic inflammation in an elderly panel cohort. Epidemiology 2010, 21:892-902.
14. Fahmy B., Cormier S.A. Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol In Vitro 2009, 23:1365-1371.
15. Fenoglio I., Greco G., Tomatis M., et al. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: Physicochemical aspects. Chem Res Toxicol 2008, 21:1690-1697.
16. Fubini B., Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med 2003, 34:1507-1516.
17. Grabinski C., Hussain S., Lafdi K., Braydich-Stolle L., Schlager J. Effect of particle dimension on biocompatibility of carbon nanomaterials. Carbon 2007, 45:2828-2835.
18. Grahame T.J., Schlesinger R.B. Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence. Air Qual Atmos Health 2010, 3:3-27.
19. Gurr J.R., Wang A.S., Chen C.H., Jan K.Y. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology 2005, 213:66-73.
20. Hirano S., Kanno S., Furuyama A. Multi-walled carbon nanotubes injure the plasma membrane of macrophages. Toxicol Appl Pharmacol 2008, 232:244-251.
21. Hondroulis E., Liu C., Li C.Z. Whole cell based electrical impedance sensing approach for a rapid nanotoxicity assay. Nanotechnology 2010, 21:315103.
22. Hsin Y.H., Chen C.F., Huang S., et al. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 2008, 179:130-139.
23. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 2005, 19:975-983.
24. Hussain S., Boland S., Baeza-Squiban A., et al. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology 2009, 260:142-149.
25. Hyeon J.W., Kim S.Y., Park J.S., et al. The association between prion proteins and A 1-42 oligomers in cytotoxicity and apoptosis. Biochem Biophys Res Commun 2012, 424:214-220.
26. Ivanov Y.D., Govorun V.M., Bykov V.A., Archakov A.I. Nanotechnologies in proteomics. Proteomics 2006, 6:1399-1414.
27. Johnson C.J., Zhukovsky N., Cass A.E., Nagy J.M. Proteomics, nanotechnology and molecular diagnostics. Proteomics 2008, 8:715-730.
28. Joo J.Y., Lee M.A., Bae S.O., Soo S. Blood biomarkers: From nanotoxicity to neurodegeneration. SPIE Newsroom 2013, accessed at http://spie.org/x92135.xml.
29. Kang S.J., Kim B.M., Lee Y.J., Chung H.W. Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes. Environ Mol Mutagen 2008, 49:399-405.
30. Kim J., Kim H.S., Lee N., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem 2008, 120:8566-8569.
31. Lequin R.M. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin Chem 2005, 51:2415-2418.
32. Leroueil P.R., Berry S.A., Duthie K., et al. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Letters 2008, 8:420-424.
33. Lewinski N., Colvin V., Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4:26-49.
34. Li N., Nel A.E. Feasibility of biomarker studies for engineered nanoparticles: what can be learned from air pollution research. J Occup Environ Med 2011, 53:S74-S79.
35. Lin W., Huang Y.W., Zhou X.D., Ma Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 2006, 217:252-259.
36. Long T.C., Tajuba J., Sama P., et al. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ Health Perspect 2007, 115:1631-1637.
37. McBain S.C., Yiu H.H., Dobson J. Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 2008, 3:169-180.
38. Nel A. Air pollution-related illness: Effects of particles. Science 2005, 308:804-806.
39. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
40. Oberdorster G., Maynard A., Donaldson K., et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2005, 2:8.
41. Ott M., Robertson J.D., Gogvadze V., Zhivotovsky B., Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci 2002, 99:1259-1263.
42. Park E.J., Yi J., Chung K.H., et al. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol Lett 2008, 180:222-229.
43. Park E.J., Kim H., Kim Y., et al. Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice. Toxicology 2010, 275:65-71.
44. Petricoin E.F., Belluco C., Araujo R.P., Liotta L.A. The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat Rev Cancer 2006, 6:961-967.
45. Pulskamp K., Diabaté S., Krug H.F. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 2007, 168:58-74.
46. Pumera M. Nanotoxicology: the molecular science point of view. Chem Asian J 2011, 6:340-348.
47. Ramachandran N., Srivastava S., Labaer J. Applications of protein microarrays for biomarker discovery. Proteomics Clin Appl 2008, 2:1444-1459.
48. Rahman I., MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 2000, 28:1405-1420.
49. Ray S., Chandra H., Srivastava S. Nanotechniques in proteomics: current status, promises and challenges. Biosens Bioelectron 2010, 25:2389-2401.
50. Rosenblatt K.P., Bryant-Greenwood P., Killian J.K., et al. Serum proteomics in cancer diagnosis and management. Annu Rev Med 2004, 55:97-112.
51. Sahu S.C., Casciano D.A. Nanotoxicity from In vivo and In vitro Models to Health Risks 2009, John Wiley, Chichester, West Sussex, UK, http://public.eblib.com/EBLPublic/PublicView.do?ptiID=470228.
52. Sayes C.M., Wahi R., Kurian P.A., et al. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci 2006, 92:174-185.
53. Somasundaran P., Fang X., Ponnurangam S., Li B. Nanoparticles: characteristics, mechanisms, and modulation of biotoxicity. KONA Powder Part J 2010, 28:38-49.
54. Srivastava S., LaBaer J. Nanotubes light up protein arrays. Nat Biotechnol 2008, 26:1244-1246.
55. Srinivas A., Rao P.J., Selvam G., et al. Oxidative stress and inflammatory responses of rat following acute inhalation exposure to iron oxide nanoparticles. Hum Exp Toxicol 2012, 31:1113-1131.
56. Sun W., Luna-Velasco A., Sierra-Alvarez R., Field J.A. Assessing protein oxidation by inorganic nanoparticles with enzyme-linked immunosorbent assay (ELISA). Biotechnol Bioeng 2012, 110:694-701.
57. 2 nanoparticles. Nanomedicine 2008, 4:226-236.
58. Thibodeau M.S., Giardina C., Knecht D.A., Helble J., Hubbard A.K. Silica-induced apoptosis in mouse alveolar macrophages is initiated by lysosomal enzyme activity. Toxicol Sci 2004, 80:34-48.
59. Uhlar C.M., Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999, 265:501-523.
60. Wan S., Huang J., Guo M., et al. Biocompatible superparamagnetic iron oxide nanoparticle dispersions stabilized with poly(ethylene glycol)-oligo(aspartic acid) hybrids. J Biomed Mater Res A 2007, 80A:946-954.
61. Wang L., Bowman L., Lu Y., et al. Essential role of p53 in silica-induced apoptosis. Am J Physiol Lung Cell Mol Physiol 2005, 288:L488-L496.
62. 2 particles: differential responses related to surface properties. Toxicology 2007, 230:90-104.
63. Warheit D.B., Reed K.L., Sayes C.M. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management. Inhal Toxicol 2009, 21:61-67.
64. Wilhelm C., Gazeau F., Roger J., Pons J.N., Bacri J.C. Interaction of anionic superparamagnetic nanoparticles with cells: Kinetic analyses of membrane adsorption and subsequent internalization. Langmuir 2002, 18:8148-8155.
65. Wong S.C., Chan C.M., Ma B.B., et al. Advanced proteomic technologies for cancer biomarker discovery. Expert Rev Proteomics 2009, 6:123-134.
66. Xiao G.G., Wang M., Li N., Loo J.A., Nel A.E. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem 2003, 278:50781-50790.
67. Yang W., Peters J.I., Williams R.O. Inhaled nanoparticles - A current review. Int J Pharm 2008, 356:239-247.
68. Zhang R., Bai Y., Zhang B., Chen L., Yan B. The potential health risk of titania nanoparticles. J Hazard Mater 2012, 211-2:404-413.
69. Zhao J., Xu L., Zhang T., Ren G., Yang Z. Influences of nanoparticle zinc oxide on acutely isolated rat hippocampal CA3 pyramidal neurons. Neurotoxicology 2009, 30:220-230.
70. Zhu X., Hondroulis E., Liu W., Li C.Z. Biosensing approaches for rapid genotoxicity and cytotoxicity assays upon nanomaterial exposure. Small 2013, http://dx.doi.org/10.1002/smll.201201593.